Physician profile
Hannah Flory
NPI 1922442912
$1,044.71
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2020: $151 · 2021: $77.93 · 2022: $27.69.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $843.27 | 2019-2022 | |
| Conmed Corporation | $41.67 | 2019 | |
| Innocoll Pharmaceuticals Limited | $28.05 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.85 | 2021 | |
| Allergan, INC. | $19.11 | 2019 | |
| Shire North American Group INC | $18.86 | 2019 | |
| Stryker Corporation | $17.31 | 2019 | |
| Acell, INC. | $14.22 | 2020 | |
| Olympus America INC. | $14.05 | 2021 | |
| Myriad Genetic Laboratories, INC. | $13.98 | 2021 | |
| Hologic INC | $12.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Flory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.